9:22 AM
Leo Group India
| ||
| ||
| Manipal varsity to offer Masters in Pharmaceutical Medicine Hindu Business Line A press release by the university said here that Hibernia College, Dublin – in collaboration with Manipal College of Pharmaceutical Sciences, Manipal University – will offer a programme in Master of Sciences in Pharmaceutical Medicine from October. See all stories on this topic » | ||
| ||
| Pharmaceutical sales rep access reducing most among oncologists in USA The Pharma Letter As more pharmaceutical companies prepare to bring new oncology drugs to market, their sales representatives face a rising hurdle – oncologists in the USA are reducing the number of times they will see them. According to the spring 2012 AccessMonitor, ... See all stories on this topic » | ||
| New method simplifies pharmaceutical production of proteins News-Medical.net Engineering researchers at the University of Arkansas have developed a method to simplify the pharmaceutical production of proteins used in drugs that treat a variety of diseases and health conditions, including diabetes, cancer, arthritis and macular ... See all stories on this topic » | ||
| Lower Macungie Township to be new home for pharmaceutical packaging ... Lehighvalleylive.com A pharmaceutical packaging company will move from New Jersey to Lower Macungie Township, creating more than 280 jobs in the Lehigh Valley, Pennsylvania Gov. Tom Corbett said today. The company, Quality Packaging Specialists International, will ... See all stories on this topic » | ||
| 4 Low-Debt Pharmaceutical Stocks Backed By Analysts Seeking Alpha With this in mind, we looked for stocks in the pharmaceutical category where debt has been kept to a minimum. The companies that made our cut have also been recently reviewed by analysts and given "Buy" or "Strong Buy" ratings. See the list below to ... See all stories on this topic » | ||
| Healthcare Review: Discovery Laboratories & Rexahn Pharmaceuticals Jump ... Reuters Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) stock plummeted 20.90% to $1.50 after the company said it has entered into definitive agreements to sell 4.0 million shares of the Company's common stock, and common stock purchase warrants to ... See all stories on this topic » | ||
| Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of ... Sacramento Bee 28, 2012 -- /PRNewswire/ -- Esperance Pharmaceuticals today announced the completion of the run-in cohort of its Phase 2, randomized, multi‐center trial of EP‑100 in combination with paclitaxel for patients with advanced ovarian cancer. EP‐100 is a ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment